GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » PE Ratio

3SBio, (FRA:YFK) PE Ratio : N/A (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is 3SBio, PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-05-16), 3SBio,'s share price is €12.55. 3SBio,'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00. Therefore, 3SBio,'s PE Ratio for today is N/A.

Warning Sign:

3SBio Inc old stock PE Ratio (=42.76) is close to 2-year high of 43.58

During the past 13 years, 3SBio,'s highest PE Ratio was 43.58. The lowest was 23.32. And the median was 31.22.

3SBio,'s EPS (Diluted) for the six months ended in Dec. 2016 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00.

As of today (2024-05-16), 3SBio,'s share price is €12.55. 3SBio,'s EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00. Therefore, 3SBio,'s PE Ratio without NRI ratio for today is N/A.

During the past 13 years, 3SBio,'s highest PE Ratio without NRI was 43.58. The lowest was 23.32. And the median was 31.22.

3SBio,'s EPS without NRI for the six months ended in Dec. 2016 was €0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00.

During the past 12 months, 3SBio,'s average EPS without NRI Growth Rate was 13.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -26.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was -20.90% per year.

During the past 13 years, 3SBio,'s highest 3-Year average EPS without NRI Growth Rate was 42.20% per year. The lowest was 0.00% per year. And the median was 0.00% per year.

3SBio,'s EPS (Basic) for the six months ended in Dec. 2016 was €0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2016 was €0.00.

Back to Basics: PE Ratio


3SBio, PE Ratio Historical Data

The historical data trend for 3SBio,'s PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, PE Ratio Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.58 19.10 N/A 39.36 24.05

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 45.87 39.36 30.37 24.05

Competitive Comparison of 3SBio,'s PE Ratio

For the Biotechnology subindustry, 3SBio,'s PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio,'s PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio,'s PE Ratio distribution charts can be found below:

* The bar in red indicates where 3SBio,'s PE Ratio falls into.



3SBio, PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

3SBio,'s PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=12.55/0.000
=N/A

3SBio,'s Share Price of today is €12.55.
For company reported semi-annually, 3SBio,'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


3SBio,  (FRA:YFK) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


3SBio, PE Ratio Related Terms

Thank you for viewing the detailed overview of 3SBio,'s PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio, (FRA:YFK) Business Description

Traded in Other Exchanges
N/A
Address
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines